DrugPatentWatch Database Preview
Details for Patent: 7,229,613
Try a free trial
See Plans and Pricing
Which drugs does patent 7,229,613 protect, and when does it expire?
Patent 7,229,613 protects WELCHOL and is included in three NDAs.
Protection for WELCHOL has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has sixty-three patent family members in eighteen countries.
Summary for Patent: 7,229,613
| Title: | Method for lowering serum glucose |
| Abstract: | A method for treating hyperglycemia and/or reducing serum glucose levels in a patient that includes administering to the patient a therapeutically effective amount of an amine polymer is disclosed. In one embodiment, the amine polymer is aliphatic. Examples of polymers useful in an embodiment of the invention include sevelamer hydrogen chloride and colesevelam. The invention includes the use of amine polymers such as a cross-linked polymer characterized by a repeat unit having the formula: ##STR00001## and salts and copolymers thereof, where n is a positive integer and x is zero or an integer between 1 and about 4. Also described is a use, for the manufacture of a medicament, of a polymer that lowers serum glucose. |
| Inventor(s): | Burke; Steven K. (Sudbury, MA), Donovan; Joanne M. (Needham, MA) |
| Assignee: | Genzyme Corporation (Cambridge, MA) |
| Application Number: | 10/125,700 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 7,229,613
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Daiichi Sankyo Inc | WELCHOL | colesevelam hydrochloride | BAR, CHEWABLE;ORAL | 210895-001 | Apr 3, 2019 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | A METHOD FOR REDUCING SERUM GLUCOSE LEVELS IN ADULTS WITH TYPE 2 DIABETES MELLITUS | ➤ Sign Up | ||||
| Daiichi Sankyo | WELCHOL | colesevelam hydrochloride | FOR SUSPENSION;ORAL | 022362-001 | Oct 2, 2009 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||||
| Daiichi Sankyo | WELCHOL | colesevelam hydrochloride | FOR SUSPENSION;ORAL | 022362-002 | Oct 2, 2009 | AB | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Daiichi Sankyo | WELCHOL | colesevelam hydrochloride | TABLET;ORAL | 021176-001 | May 26, 2000 | AB | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,229,613
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 331525 | ➤ Sign Up | |||
| Austria | 380553 | ➤ Sign Up | |||
| Austria | 390927 | ➤ Sign Up | |||
| Australia | 2002252632 | ➤ Sign Up | |||
| Australia | 2002257145 | ➤ Sign Up | |||
| Australia | 2002257147 | ➤ Sign Up | |||
| Brazil | 0209020 | ➤ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
